AI English summary of an SEC filing — figures as filed
Sempra SREThe company said the PUCT approved Oncor's comprehensive base rate review final order on April 17, 2026, providing for an annual revenue requirement of about $6.97 billion, an increase of about $560 million, or 8.7%, over Oncor's adjusted annualized revenues as provided in the rate application.
Key points
AI summaryThe company said the PUCT approved Oncor's comprehensive base rate review final order on April 17, 2026, providing for an annual revenue requirement of about $6.97 billion, an increase of about $560 million, or 8.7%, over Oncor's adjusted annualized revenues as provided in the rate application.
Oncor's regulatory capital structure will change under the order to 56.5% debt to 43.5% equity, with an authorized return on equity of 9.75% and an authorized cost of debt of 4.94%, the company said. Previously, the structure was 57.5% debt to 42.5% equity, with an authorized return on equity of 9.70% and an authorized cost of debt of 4.39%.
The company said the order sets the annual accrual for the self-insurance reserve, which covers storm costs and other self-insured losses, at $200 million in rates, up from the $122 million currently recovered in rates. The related regulatory assets and liabilities will be amortized over 5 years.
The company said Oncor may surcharge the difference between the new billing rates and its current rates for the period from January 1, 2026 until the new rates take effect. The new rates take effect 45 days after the date of the final order, and the surcharge will be recovered during 2026 through a separate filing.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
PUCT Approves Final Order on Oncor Annual Revenue Requirement of About $6.97 billion
The company said the PUCT approved Oncor's comprehensive base rate review final order on April 17, 2026, providing for an annual revenue requirement of about $6.97 billion, an increase of about $560 million, or 8.7%, over Oncor's adjusted annualized revenues as provided in the rate application.
Source · Based on the filing body and exhibits
Oncor Changes Regulatory Capital Structure, Authorized Return on Equity and Cost of Debt
Oncor's regulatory capital structure will change under the order to 56.5% debt to 43.5% equity, with an authorized return on equity of 9.75% and an authorized cost of debt of 4.94%, the company said. Previously, the structure was 57.5% debt to 42.5% equity, with an authorized return on equity of 9.70% and an authorized cost of debt of 4.39%.
Source · Based on the filing body and exhibits
Self-Insurance Reserve Accrual and Regulatory Asset and Liability Amortization Period
The company said the order sets the annual accrual for the self-insurance reserve, which covers storm costs and other self-insured losses, at $200 million in rates, up from the $122 million currently recovered in rates. The related regulatory assets and liabilities will be amortized over 5 years.
Source · Based on the filing body and exhibits
Timing of New Rates and Surcharge Recovery in 2026
The company said Oncor may surcharge the difference between the new billing rates and its current rates for the period from January 1, 2026 until the new rates take effect. The new rates take effect 45 days after the date of the final order, and the surcharge will be recovered during 2026 through a separate filing.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…